SLC1A2 and myeloid sarcoma: In combination with the previously reported reduction in EAAT2 expression at the periphery of MS lesions [15, 62], glutamate release via system xc− might lead to excitotoxicity, in accordance with elevated glutamate levels reported in NAWM of MS patients [11].